These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19856321)

  • 1. Bayesian methods of analysis for cluster randomized trials with count outcome data.
    Clark AB; Bachmann MO
    Stat Med; 2010 Jan; 29(2):199-209. PubMed ID: 19856321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian methods for analysis of binary outcome data in cluster randomized trials on the absolute risk scale.
    Thompson SG; Warn DE; Turner RM
    Stat Med; 2004 Feb; 23(3):389-410. PubMed ID: 14748035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructing intervals for the intracluster correlation coefficient using Bayesian modelling, and application in cluster randomized trials.
    Turner RM; Omar RZ; Thompson SG
    Stat Med; 2006 May; 25(9):1443-56. PubMed ID: 16220510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials.
    Ukoumunne OC
    Stat Med; 2002 Dec; 21(24):3757-74. PubMed ID: 12483765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian analysis of the differences of count data.
    Karlis D; Ntzoufras I
    Stat Med; 2006 Jun; 25(11):1885-905. PubMed ID: 16252270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing methods for calculating confidence intervals for vaccine efficacy.
    Ewell M
    Stat Med; 1996 Nov 15-30; 15(21-22):2379-92. PubMed ID: 8931208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel analysis of group-randomized trials with binary outcomes.
    Kim HY; Preisser JS; Rozier RG; Valiyaparambil JV
    Community Dent Oral Epidemiol; 2006 Aug; 34(4):241-51. PubMed ID: 16856945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS.
    Lambert PC; Sutton AJ; Burton PR; Abrams KR; Jones DR
    Stat Med; 2005 Aug; 24(15):2401-28. PubMed ID: 16015676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values.
    Li J; Yang X; Wu Y; Shoptaw S
    Stat Med; 2007 May; 26(12):2519-32. PubMed ID: 17106918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for analyzing multilevel cluster-randomized studies with binary outcomes collected at varying intervals of time.
    Olsen MK; DeLong ER; Oddone EZ; Bosworth HB
    Stat Med; 2008 Dec; 27(29):6055-71. PubMed ID: 18825655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical Bayes models of Poisson clinical trials and sample size determination.
    Zaslavsky BG
    Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian inference for finite mixtures of univariate and multivariate skew-normal and skew-t distributions.
    Frühwirth-Schnatter S; Pyne S
    Biostatistics; 2010 Apr; 11(2):317-36. PubMed ID: 20110247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecological-type inference in matched-pair studies with fixed marginal totals.
    Barker LK; Griffin SO; Jeon S; Gray SK; Vidakovic B
    Stat Med; 2011 Feb; 30(5):541-8. PubMed ID: 21312218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical Bayesian design and analysis for drug and device clinical trials.
    Hobbs BP; Carlin BP
    J Biopharm Stat; 2008; 18(1):54-80. PubMed ID: 18161542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian methods of analysis for cluster randomized trials with binary outcome data.
    Turner RM; Omar RZ; Thompson SG
    Stat Med; 2001 Feb; 20(3):453-72. PubMed ID: 11180313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian approach to jointly modeling toxicity and biomarker expression in a phase I/II dose-finding trial.
    Bekele BN; Shen Y
    Biometrics; 2005 Jun; 61(2):343-54. PubMed ID: 16011680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.